ArticleBMC cancer2023

ARPC5 acts as a potential prognostic biomarker that is associated with cell proliferation, migration and immune infiltrate in gliomas.

Yue Ming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.